Head of National Cancer Institute to Serve as Interim FDA Chief

01:40 EDT 13 Mar 2019 | Medscape

NCI Director Sharpless will lead the regulatory agency during the search for a permanent chief. Deputy NCI Chief Lowy will serve as acting director during Sharpless' absence.
Medscape Medical News

Original Article: Head of National Cancer Institute to Serve as Interim FDA Chief

More From BioPortfolio on "Head of National Cancer Institute to Serve as Interim FDA Chief"